| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |